Llusern Scientific Announces Key Appointments to Strengthen its Executive Team
CARDIFF, United Kingdom, July 22, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific, a point-of-care diagnostics company, today announces the appointments of Bob Yang as Chief Medical Officer (CMO), Maddy Kennedy as Chief Financial Officer (CFO), and Mark Preston as Chief Technology Officer (CTO). These strategic appointments strengthen Llusern's leadership team as the company builds on its recent ISO 13485 certification and progresses towards IVDR certification, positioning Lodestar DX for upcoming commercial launches across Europe for treatment-directing diagnosis of urinary tract infections (UTIs).
Bob Yang joins Llusern Scientific as Chief Medical Officer. A highly accomplished urology consultant, Mr. Yang brings extensive expertise in complex and recurrent UTIs and male and female incontinence. He has made significant contributions to antibiotic-free treatment options for recurrent UTIs and has been pioneering research in sub-lingual UTI vaccines and male incontinence devices. His expertise will directly complement Llusern's mission to revolutionize UTI diagnostics and support antimicrobial stewardship through the Lodestar DX system, a rapid diagnostic platform designed to enhance clinical decision-making. He is Lead Editor for Springer Nature academic textbooks on Urinary Tract Infections and Male Incontinence, solidifying his standing as one of the global leaders in urological research and practice. Mr. Yang continues to pioneer in his field as a urology consultant at the Royal Berkshire NHS Foundation Hospital and an Associate Lecturer at Oxford University.
'Joining Llusern Scientific is an exciting opportunity to contribute to the growth of innovative diagnostic solutions that will improve patient outcomes globally,' said Bob Yang, Chief Medical Officer of Llusern Scientific. 'The Lodestar DX system offers clinicians a powerful tool to make precise treatment decisions in a single visit, thereby enabling them to combat antimicrobial resistance through improved antibiotic stewardship.'
As Chief Financial Officer, Maddy Kennedy brings over 25 years of experience in financial strategy, investor relations, and corporate governance to Llusern Scientific. She will play a crucial role in supporting Llusern's fundraising activities and steering its expansion into global markets. Known for her ability to translate complex development programs into clear financial plans, Maddy has successfully guided life sciences and technology businesses through strategic growth, M&A, IPOs, and exit planning. Her leadership roles at companies such as Maxwellia, Kesmalea Therapeutics, and Psioxus Therapeutics have equipped her with expertise in scaling operations and securing funding. She brings strong governance expertise from Non-Executive Director roles at Nuformix plc, Heartbeat CIC, and Tetris Pharma. She is currently also CFO at PBD Biotech and Fermtech.
'I am excited to join Llusern Scientific at this crucial stage of its development,' said Maddy Kennedy, Chief Financial Officer of Llusern Scientific. 'With its innovative Lodestar DX system poised for expansion into new markets, I look forward to supporting Llusern's growth and overseeing the financial operations needed to achieve its global ambitions.'
Mark Preston joins Llusern Scientific as Chief Technology Officer, bringing extensive expertise in biotech, data analytics, and cloud technologies. As CTO, Mark will lead the development of Lodestar DX overseeing technological innovation, scalability, and compliance. Mark's early career includes experience in embedded systems and devices at Sony and Panasonic, working on networking hardware, mobile phones, and microscopes. His later work in app development, AI-driven insights, and workflow optimization enabled him to deliver scalable, secure, and compliant solutions for start-ups and global organizations, including vaccine manufacturers. As a Founder and Managing Director of consultancy firm Prismea, Mark helps biotech companies innovate with data analytics, cloud systems, and regulatory compliance as well as navigating medical regulatory frameworks with organizations such as the MHRA.
'I've been impressed by the Lodestar DX system and its ability to deliver treatment directing diagnosis of UTIs at the point of care,' said Mark Preston, Chief Technology Officer. 'I look forward to supporting the company's efforts to bring precision diagnostics to healthcare settings worldwide.'
Emma Hayhurst, Co-founder and CEO of Llusern Scientific, commented:'We are thrilled to welcome Bob, Maddy, and Mark to our executive leadership team. Their deep expertise in urology, finance, and technology will be instrumental in ensuring Llusern remains at the forefront of providing precise, accessible diagnostic solutions that deliver improved outcomes for patients suffering from UTIs.'
Notes to Editors
About Llusern ScientificLlusern Scientific is a treatment-directing molecular diagnostics company, developing fast, accurate, and accessible tools to guide real-time clinical decision-making at the point-of-care. Our flagship solution, Lodestar DX, is a portable diagnostic device that delivers lab-accurate results for urinary tract infections (UTIs) in around half an hour. It is based on isothermal LAMP technology (not PCR) without the need for DNA extraction or centralized lab infrastructure. With industry-leading sensitivity and specificity, Lodestar DX empowers clinicians to diagnose and treat specific microbial infections with precision in a single visit, thereby improving patient outcomes. As well as providing guidance on the best treatment option based on the specific microbial infection, Lodestar DX also provides a clear 'rule-out' decision where antibiotics are not necessary, helping to reduce antimicrobial resistance through antibiotic stewardship.
Building on success in the UK, Llusern is preparing for commercial launches across India and the MENA region in 2025 and the US in 2026. Llusern is committed to transforming diagnostic pathways and making precision medicine equitable, portable, and fast. Due to its small size and ease of portability Lodestar DX is particularly suitable for resource limited and decentralised healthcare settings including care homes, mobile diagnostics, and community diagnostic centres. Additionally Lodestar DX has uses within paediatrics, urology, and other secondary care settings.
The Lodestar DX UTI testing system has been independently evaluated in studies by University of Oxford, Norfolk and Norwich University Hospital, Southampton University, and Public Health Wales. The company was established in 2020 as a spin-out from the University of South Wales, UK.
For more information, visit https://llusern.co.uk/ and follow us on LinkedIn.
Media Contacts
Llusern ScientificMartyn Lewis +44 (0) 7825 708936martyn@llusern.co.uk
Scius CommunicationsKatja Stout +44 (0) 7789435990katja@sciuscommunications.com
Daniel Gooch +44 (0) 7747875479daniel@sciuscommunications.comSign in to access your portfolio
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Amazon faces UK lawsuits worth up to $5.4 billion from retailers, consumers
LONDON (Reuters) -Amazon faces two mass lawsuits from retailers and consumers worth up to 4 billion pounds ($5.4 billion) for allegedly abusing its dominant position, after a London tribunal on Thursday certified the cases could proceed. Andreas Stephan, a competition law academic, is bringing one of the cases on behalf of over 200,000 third-party retailers, worth up to 2.7 billion pounds. His lawyers allege that Amazon manipulates the "Buy Box" feature on its website to its own advantage and favours products that use Amazon's own logistics centres and delivery network. Consumer advocate Robert Hammond is separately bringing a case valued at up to 1.3 billion pounds on behalf of millions of Amazon customers for similar alleged abuses of dominance. Amazon argued that the Competition Appeal Tribunal should certify the cases to proceed, an early step in the proceedings, including because the economic methodology for proving the cases was flawed. But the tribunal certified both cases on an opt-out basis, meaning members of the claimant class will be part of the case unless they decide otherwise. An Amazon spokesperson said: "These claims are without merit and we're confident that will become clear through the legal process. "Amazon has always focused on supporting the 100,000 businesses that sell their products on our UK store, and more than half of all physical product sales on our UK store are from independent selling partners." Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Thousands of cancer cases could be prevented with more breast removal surgeries
Thousands of breast cancer cases could potentially be prevented if more women were offered 'risk reducing' breast removal surgery, a study suggests. Breast removal surgery, also known as a mastectomy, is offered to treat breast cancer in some women. It can also be offered to women who are deemed to be high risk of the disease to prevent them from getting it in the first place. A study has found that if more women were given preventative mastectomies, then about 6,500 cases of breast cancer could be prevented each year. Risk-reducing mastectomies (RRM) are currently only offered to women with the BRCA1, BRCA2, PALB2 genes, experts said. But the new analysis suggests that some women with other genes linked to a higher risk of breast cancer – including ATM, CHEK2, RAD51C, RAD51D – who may also be at higher risk due to a number of other factors may benefit from RRM if they are assessed as having a high risk of disease. These other factors can include a family history of breast cancer, the number of children they have had, whether or not they breast fed and mammogram density. Women in the UK have an 11% chance of developing breast cancer across their lifetime. Medics can calculate a woman's risk of breast cancer using tools which combine the effect of various risk factors. This is your breast check reminder! Learn the signs and symptoms of breast — Breast Cancer Now (@BreastCancerNow) May 6, 2025 Researchers from Queen Mary University of London and the London School of Hygiene and Tropical Medicine (LSHTM) found that if health officials could identify all women aged 30 to 55 who have a 35% or higher risk of breast cancer, and they all went on to have RRM, then an estimated 6,538 breast cancer cases could be prevented in the UK each year. This is the equivalent of around 11% of the 59,000 women in the UK who are diagnosed with breast cancer each year. The academics point out that women who have one of the other genes linked to breast cancer, who may be at high risk of disease, could potentially be found by a mechanism called 'cascade testing' – where genetic tests are offered to family members of women who have been found to have these different genes linked to breast cancer. The economic evaluation study, published in the journal JAMA Oncology, concludes: 'Undergoing RRM appears cost-effective for women at 30-55 years with a lifetime BC-risk 35% (or more). 'The results could have significant clinical implications to expand access to RRM beyond BRCA1/BRCA2/PALB2 pathogenic variant carriers.' Corresponding author on the paper, Professor Ranjit Manchanda, professor of gynaecological oncology at Queen Mary and consultant gynaecological oncologist, said: 'We for the first time define the risk at which we should offer RRM. 'Our results could have significant clinical implications to expand access to mastectomy beyond those patients with known genetic susceptibility in high penetrance genes- BRCA1/ BRCA2/ PALB2 – who are traditionally offered this. 'This could potentially prevent can potentially prevent (around) 6500 breast cancer cases annually in UK women. 'We recommend that more research is carried out to evaluate the acceptability, uptake, and long-term outcomes of RRM among this group'. Dr Rosa Legood, associate professor in health economics at LSHTM, added: 'Undergoing RRM is cost-effective for women (aged) 30 to 55-years with a lifetime breast cancer risk of 35% or more. 'These results can support additional management options for personalised breast cancer risk prediction enabling more women at increased risk to access prevention.' Women deemed to be at high risk of breast cancer can also be offered regular screening and medication. Louise Grimsdell, Breast Cancer Now senior clinical nurse specialist, said: 'While this modelling provides valuable insights into the cost-effectiveness of risk-reducing mastectomy for women with a high risk of developing breast cancer, each individual must be offered all risk-management options that are suitable for them. 'Choosing to have risk-reducing surgery is a complex and deeply personal decision that comes with emotional and physical implications. 'So, it's vital women can consider all their options, including screening and risk-reducing medications, and are supported by their clinician to make an informed decision that's right for them. 'It's also crucial that the unacceptably long waits that far too many women who chose risk-reducing surgery are facing are urgently tackled.'
Yahoo
13 minutes ago
- Yahoo
Bank Outsourcing, Cost-cutting Demands, Digital Banking, Real-time Monitoring, AI Integration, and Improved Security Propel Growth
The global ATM Managed Services Market is projected to reach $12.29 billion by 2033, growing at a CAGR of 4.25% from 2025 to 2033, up from $8.45 billion in 2024. Rising demand for cost-cutting, increased bank outsourcing, digital banking adoption, real-time monitoring needs, AI integration, and enhanced security drive market growth. Key segments include ATM replenishment, incident and network management across various locations such as offsite, onsite, and mobile ATMs. The expansion is notable in North America, Europe, and rapidly developing regions such as Asia-Pacific. Major players include NCR Atleos, Diebold Nixdorf, and Fiserv. The market's evolution is fueled by technological advancements, financial inclusion efforts, and strategic alliances. ATM Managed Services Market Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "ATM Managed Services Market - Technology & Forecast Outlook 2025-2033" report has been added to Managed Services Market is expected to reach US$ 12.29 billion by 2033 from US$ 8.45 billion in 2024, with a CAGR of 4.25% from 2025 to 2033 Cost-cutting demands, a rise in bank outsourcing, the adoption of digital banking, the requirement for real-time monitoring, AI integration, improved security, and an increase in ATM usage in developing cities are the main factors propelling the market for ATM managed services. Due to the growing demand for financial institutions to streamline operations and cut expenses, the global market for ATM managed services is expanding significantly. These services include a variety of options, such as ATM administration, maintenance, and monitoring, which guarantees seamless operation and reduces downtime. By facilitating real-time monitoring and predictive maintenance, the use of cutting-edge technologies like artificial intelligence (AI) and the Internet of Things (IoT) has further fueled market development. Additionally, banks are outsourcing ATM operations to specialized service providers as a result of the increased focus on improving customer experience and maintaining regulatory compliance. The market is seeing a rise in demand for all-inclusive ATM managed services solutions as a need for sophisticated ATM services to access a range of intricate activities has grown as a result of the banking, financial services, and insurance (BFSI) industry's significant development. The increasing use of money transaction machines and growing maintenance and security concerns, which are some of the primary drivers propelling the market expansion, further support this. Accordingly, the increasing prevalence of fraudulent actions, such as magnetic stripe skimming, and the widespread use of debit cards by customers have made it easier for ATM managed services to be widely adopted, which is contributing to further growth. Furthermore, the market is expanding as a result of the positive actions being taken by the governments of a number of nations to prevent the use of magstripe cards by using EMV chips for improved authentication. Additionally, the market is expanding due to the development of self-service software, which coincides with the widespread integration of Internet of Things (IoT) solutions and mobile-based technologies with ATM managed services. A favorable outlook for the market is being created by additional factors, such as the quick digitization, strategic partnerships among financial institutions, and the growing use of blockchain, near field communication (NFC), quicker response (QR), and artificial intelligence (AI) in ATM managed Factors Driving the ATM Managed Services Market Growth Focus on Core CompetenciesFinancial institutions may reduce operations and concentrate on their core strengths, including improving client experience, creating new financial products, and advancing digital transformation, by outsourcing ATM managed services. Internal ATM management takes a lot of time, money, and technical resources, which can take focus away from strategic goals. Banks can assign time-consuming operations like software upgrades, hardware maintenance, cash replenishment, and compliance monitoring to specialist service providers. In addition to increasing operational effectiveness, this strategy enables organizations to better meet the needs of their clients and the market. Banks may now devote more resources to innovation, consumer interaction, and growing their digital and mobile banking ecosystems as they are no longer burdened with managing ATM FootprintThe market for ATM managed services is mostly driven by the growth of ATM networks, especially in developing nations and underserved rural regions. Banks and other financial institutions are installing more ATMs as financial inclusion becomes a top focus in order to boost accessibility and satisfy the rising demand for self-service and cash-based transactions. However, significant operational, technical, and logistical assistance is needed to manage a large ATM network. Consistent performance, uptime, and adherence to industry standards are guaranteed when these services are outsourced. Installation, cash loading, security, maintenance, and real-time monitoring may all be handled effectively by managed services providers over large geographic areas. The need for dependable and scalable managed services solutions that ensure business continuity and offer a flawless customer experience is increased by the expansion of the ATM AdvancementsThe market for ATM managed services is changing as a result of technological developments that make operations more effective, intelligent, and responsive. Service providers may monitor ATMs in real time, identify irregularities, and carry out predictive maintenance by combining artificial intelligence (AI), the Internet of Things (IoT), and predictive analytics. This lowers downtime and improves customer satisfaction. Additionally, smart technologies streamline supply schedules, guarantee operational continuity, and enhance cash forecasting. Furthermore, preemptive reactions are made possible by AI-driven insights that assist in identifying fraud and security concerns. IoT sensors can keep an eye on connection, temperature, and hardware health to stop problems. These developments promote a safer and more convenient ATM experience in addition to lowering operating expenses. Technology is a key factor in determining managed services strategies as financial organizations embrace digital in the ATM Managed Services Market Service Reliability and DowntimeIn the market for ATM managed services, service dependability is crucial. Consumers anticipate having round-the-clock access to ATMs for transactions such as cash withdrawals and balance inquiries. Customer satisfaction and confidence can be severely impacted by even brief outages, particularly in places with limited financial facilities. Constant monitoring, prompt issue resolution, and proactive maintenance - often across geographically scattered locations - are necessary to ensure high uptime. For financial institutions, unplanned outages brought on by hardware malfunctions, network problems, or software bugs can result in lost income, harm to their brand, and client attrition. For managed service providers to minimize the impact of disruptions on end users and promptly fix issues and preserve operational continuity, they must set up effective service-level agreements (SLAs), deploy real-time monitoring systems, and keep a knowledgeable support Management LogisticsAn intricate and crucial component of ATM operations is efficient cash handling. It's a fine balance to make sure every ATM has enough cash on hand to satisfy consumer demand without going overboard. Based on transaction patterns, historical data, and seasonal fluctuations, managed service providers must predict cash consumption with accuracy. Cashouts brought on by poor forecasting can annoy clients and harm a bank's image. On the other hand, having too much cash in machines raises operating expenses and security threats. Another logistical problem is coordinating prompt cash replenishment across extensive ATM networks, particularly in rural or high-risk regions. Cash logistics is a resource-intensive but crucial job in ATM managed services as providers also have to coordinate with armored carriers, ensure safe transit, and adhere to cash-handling Managed Services Market Overview by RegionsBecause of sophisticated banking infrastructure and high outsourcing rates, the market for ATM managed services is expanding rapidly in North America and Europe. As more ATMs are installed, Asia-Pacific is growing quickly, while financial inclusion initiatives are driving stable development in Latin America and the Middle East. Company Analysis: Overview, Key Persons, Recent Development & Strategies, Revenue Analysis NCR Atleos Diebold Nixdorf, Inc. Euronet Worldwide, Inc. Fiserv, Inc. AGS Transact Technologies Ltd. Brink's Incorporated Hitachi, Ltd. CMS Info Systems Limited Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $8.45 Billion Forecasted Market Value (USD) by 2033 $12.29 Billion Compound Annual Growth Rate 4.2% Regions Covered Global Key Topics Covered: 1. Introduction2. Research Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Global ATM Managed Services Market5.1 Historical Market Trends5.2 Market Forecast6. ATM Managed Services Market Share Analysis6.1 By Service Type6.2 By ATM Locations6.3 By Countries7. Service Type7.1 ATM Replenishment and Currency Management7.2 Incident Management7.3 Network Management7.4 Security Management7.5 Other Service Types8. ATM Locations8.1 Offsite ATMs8.2 Onsite ATMs8.3 Mobile ATMs8.4 Worksite ATMs9. Countries9.1 North America9.1.1 United States9.1.2 Canada9.2 Europe9.2.1 France9.2.2 Germany9.2.3 Italy9.2.4 Spain9.2.5 United Kingdom9.2.6 Belgium9.2.7 Netherlands9.2.8 Turkey9.3 Asia Pacific9.3.1 China9.3.2 Japan9.3.3 India9.3.4 South Korea9.3.5 Thailand9.3.6 Malaysia9.3.7 Indonesia9.3.8 Australia9.3.9 New Zealand9.4 Latin America9.4.1 Brazil9.4.2 Mexico9.4.3 Argentina9.5 Middle East & Africa9.5.1 Saudi Arabia9.5.2 UAE9.5.3 South Africa10. Porter's Five Forces Analysis10.1 Bargaining Power of Buyers10.2 Bargaining Power of Suppliers10.3 Degree of Rivalry10.4 Threat of New Entrants10.5 Threat of Substitutes11. SWOT Analysis11.1 Strength11.2 Weakness11.3 Opportunity11.4 Threat12. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment ATM Managed Services Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio